NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NASDAQ · Medical Instruments & Supplies · USD

Intuitive Surgical, Inc. (ISRG) Stock Analysis

Intuitive Surgical, Inc. (ISRG) is a Medical Instruments & Supplies stock listed on NASDAQ and quoted in US Dollar.

ISRG

$366.70

−$3.13 (−0.85%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare ISRG with… →

ISRG Key Statistics

As of Sep 4, 2026
Trading
Open
$367.81
Previous Close
$369.83
Day's Range
363.23–369.55
52-Week Range
328.57–603.88
Volume
2.08M
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
1.47
Valuation
Market Cap
$131.38B
P/E Ratio
42.39
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
30.38
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
1.61
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
11.91
EPS (ttm)Profit attributable to each share over the last twelve months.
8.65
Financials (FY)
Revenue (FY)
$10.06B+20.51%
Net Income (FY)
$2.86B+22.97%
Profit marginThe share of revenue left as profit after all costs and taxes.
28.45%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
358.28M
1-Year Return
−19.32%
Dividend and dates
Earnings Date
October 20, 2026estimated
Avg Volume
3.00M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

ISRG Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−35.25%
2025+8.51%
2024+54.72%
2023+27.14%
2022−26.15%
2021+31.76%
2020+38.39%
2019+23.43%
2018+31.23%
2017+72.64%
2016 (partial year)−8.47%

As of September 4, 2026.

ISRG Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$10.06B$2.86B28.4%
2024$8.35B$2.32B27.8%
2023$7.12B$1.80B25.2%
2022$6.22B$1.32B21.3%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$10.06B$6.64B$2.95B$2.86B28.4%
2024$8.35B$5.63B$2.35B$2.32B27.8%
2023$7.12B$4.73B$1.77B$1.80B25.2%
2022$6.22B$4.20B$1.58B$1.32B21.3%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

ISRG Valuation vs Medical Instruments & Supplies Median

Median of 55 stocks
MetricISRGMedical Instruments & Supplies medianvs median
P/E42.3935.6119% above
P/S ratio11.913.173.8x the median
Profit margin28.45%0.85%27.6 pts above

Medians across 55 Medical Instruments & Supplies stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

All 20 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Intuitive Surgical, Inc. (ISRG) carries a market capitalisation of $131.38B. The company sits in the Healthcare sector, in the Medical Instruments & Supplies industry. The company reports 17,021 employees.

The 52-week range on file runs from $328.57 to $603.88. The most recent close on file for ISRG is $366.70, dated September 4, 2026. That is −$3.13 (−0.85%) against the previous close. The latest close sits 11.6% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $10.06B. That is +20.51% against the prior fiscal year, when revenue was $8.35B. Net income for the same year was $2.86B. That is +22.97% against the prior fiscal year. Profit margin runs at 28.45%. That is 27.6 percentage points above the Medical Instruments & Supplies median of 0.85%. Earnings per share on a trailing basis come to 8.65.

Across the 4 fiscal years on file, revenue moves from $6.22B in 2022 to $10.06B in 2025. Of those 4 years, 4 report positive net income.

Valuation Assessment

ISRG trades at a trailing price-to-earnings ratio of 42.39. That is 19.02% above the Medical Instruments & Supplies median of 35.61. The forward P/E on file is 30.38. The PEG ratio, which sets the P/E against expected earnings growth, reads 1.61. The price-to-sales ratio is 11.91. On price-to-sales that is 3.8 times the Medical Instruments & Supplies median of 3.17. 55 Medical Instruments & Supplies companies report these metrics, and the medians quoted come from that group.

Beta against the wider market is reported at 1.47. Daily returns over the trailing 10 years annualize to a volatility of 33.11%. Over the trailing twelve months the price has returned −19.32%. Across 10 years the annualized return works out at +16.97%.

Growth & Income

The record shows no dividend for ISRG.

So far in 2026 the price is −35.25%. The strongest complete calendar year on file is 2017 at +72.64%; the weakest is 2022 at −26.15%. Of the 9 complete calendar years on file, 8 finished higher.

Peer Comparison

Intuitive Surgical, Inc. (ISRG) operates in the Medical Instruments & Supplies industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Intuitive Surgical, Inc. ISRG $131.38B 42.4
Becton, Dickinson and Company BDX $50.32B 32.0
Medline Inc. MDLN $49.23B 45.7
Alcon Inc. ALC $34.08B 55.1

The Medical Instruments & Supplies industry average P/E ratio is 35.6x. Intuitive Surgical, Inc. trades at a P/E of 42.4.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Instruments & Supplies Stocks

BDX

Becton, Dickinson and Company

$50.32B

 MDLN

Medline Inc.

$49.23B

 ALC

Alcon Inc.

$34.08B

 RMD

ResMed Inc.

$32.94B

 WST

West Pharmaceutical Services, Inc.

$23.93B

 HOLX

Hologic, Inc.

$16.97B
View all Medical Instruments & Supplies stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About Intuitive Surgical, Inc.

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of customer service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. It sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.

Visit website →